Quarterly report pursuant to Section 13 or 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Fair Value, Assets Measured on Nonrecurring Basis

At September 30, 2018 and December 31, 2017, intangible assets were measured at fair value on a nonrecurring basis as shown in the following tables.

 

    Quoted Price in Active Markets for Identical Assets (Level 1)     Significant Other Observable Inputs (Level 2)     Significant Unobservable Inputs
(Level 3)
    Balance at
September 30,
2018
    Impairment Loss  
Patents and other technologies   $     $     $ 1,337,582     $ 1,337,582     $  
                                         

 

    Quoted Price in Active Markets for Identical Assets
(Level 1)
    Significant Other Observable Inputs
(Level 2)
    Significant Unobservable Inputs
(Level 3)
    Balance at December 31, 2017     Impairment Loss  
Patents and other technologies   $     $     $ 1,583,260     $ 1,583,260     $ 923,769  
Goodwill                             397,569  
Total   $     $     $ 1,583,260     $ 1,583,260     $ 1,321,338  
Schedule of cash balances by geographic area

At September 30, 2018 and December 31, 2017, the Company’s cash balances by geographic area were as follows:

 

Country:   September 30, 2018     December 31, 2017  
             
United States   $ 2,155,324       56.6 %   $ 1,700,024       56.2 %
China     1,654,815       43.4 %     1,327,009       43.8 %
Total cash   $ 3,810,139       100.0 %   $ 3,027,033       100.0 %
Schedule of reconciliation of basic and diluted net income (loss) per share

The following table presents a reconciliation of basic and diluted net loss per share:

 

    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
      2018       2017       2018       2017  
Net loss available to Avalon GloboCare Corp. common shareholders for basic and diluted net loss per share of common stock   $ (2,344,670 )   $ (710,729 )   $ (5,120,643 )   $ (1,690,570 )
Weighted average common stock outstanding - basic and diluted     72,573,462       64,628,622       71,611,375       63,958,292  
Net loss per common share attributable to Avalon GloboCare Corp. common shareholders - basic and diluted   $ (0.03 )   $ (0.01 )   $ (0.07 )   $ (0.03 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive:

 

    Three Months Ended September 30,     Nine Months Ended September 30,  
    2018     2017     2018     2017  
Stock options     2,670,000       484,448       2,670,000       484,448  
Warrants     578,891             578,891        
Potentially dilutive securities     3,248,891       484,448       3,248,891       484,448